GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 848 filers reported holding GLAXOSMITHKLINE PLC in Q1 2019. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $146,000 | +5.8% | 3,361 | +6.4% | 0.01% | +20.0% |
| Q1 2022 | $138,000 | -0.7% | 3,160 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $139,000 | +49.5% | 3,160 | +30.0% | 0.01% | +25.0% |
| Q3 2021 | $93,000 | +47.6% | 2,430 | +53.5% | 0.00% | +33.3% |
| Q2 2021 | $63,000 | +18.9% | 1,583 | +6.2% | 0.00% | +50.0% |
| Q1 2021 | $53,000 | -37.6% | 1,491 | -35.5% | 0.00% | -50.0% |
| Q4 2020 | $85,000 | +6.2% | 2,311 | +8.1% | 0.00% | -20.0% |
| Q3 2020 | $80,000 | +2.6% | 2,137 | +11.3% | 0.01% | 0.0% |
| Q2 2020 | $78,000 | 0.0% | 1,920 | -6.4% | 0.01% | -16.7% |
| Q1 2020 | $78,000 | -6.0% | 2,051 | +16.1% | 0.01% | +20.0% |
| Q4 2019 | $83,000 | +43.1% | 1,766 | +30.8% | 0.01% | +25.0% |
| Q3 2019 | $58,000 | +7.4% | 1,350 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $54,000 | -3.6% | 1,350 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $56,000 | -12.5% | 1,350 | -18.9% | 0.00% | -20.0% |
| Q4 2018 | $64,000 | -13.5% | 1,665 | -10.0% | 0.01% | 0.0% |
| Q3 2018 | $74,000 | -1.3% | 1,850 | 0.0% | 0.01% | -16.7% |
| Q2 2018 | $75,000 | -29.2% | 1,850 | -31.7% | 0.01% | -33.3% |
| Q1 2018 | $106,000 | +6.0% | 2,710 | -3.6% | 0.01% | 0.0% |
| Q4 2017 | $100,000 | -35.5% | 2,810 | -26.2% | 0.01% | -35.7% |
| Q3 2017 | $155,000 | -1.9% | 3,810 | +3.6% | 0.01% | -6.7% |
| Q2 2017 | $158,000 | +1.9% | 3,676 | 0.0% | 0.02% | 0.0% |
| Q1 2017 | $155,000 | -19.3% | 3,676 | -26.1% | 0.02% | -25.0% |
| Q4 2016 | $192,000 | -25.3% | 4,976 | -16.7% | 0.02% | -31.0% |
| Q3 2016 | $257,000 | -9.5% | 5,976 | -8.7% | 0.03% | -9.4% |
| Q2 2016 | $284,000 | +7.2% | 6,545 | 0.0% | 0.03% | +3.2% |
| Q1 2016 | $265,000 | +0.4% | 6,545 | 0.0% | 0.03% | 0.0% |
| Q4 2015 | $264,000 | +3.1% | 6,545 | -1.5% | 0.03% | 0.0% |
| Q3 2015 | $256,000 | -8.9% | 6,645 | -1.5% | 0.03% | 0.0% |
| Q2 2015 | $281,000 | -9.6% | 6,745 | 0.0% | 0.03% | -8.8% |
| Q1 2015 | $311,000 | +8.0% | 6,745 | 0.0% | 0.03% | +6.2% |
| Q4 2014 | $288,000 | -15.3% | 6,745 | -8.8% | 0.03% | -17.9% |
| Q3 2014 | $340,000 | -13.9% | 7,395 | 0.0% | 0.04% | -11.4% |
| Q2 2014 | $395,000 | -13.0% | 7,395 | -12.9% | 0.04% | -17.0% |
| Q1 2014 | $454,000 | +0.2% | 8,495 | 0.0% | 0.05% | -3.6% |
| Q4 2013 | $453,000 | +9.4% | 8,495 | +3.0% | 0.06% | -1.8% |
| Q3 2013 | $414,000 | -16.5% | 8,245 | -17.1% | 0.06% | -22.2% |
| Q2 2013 | $496,000 | – | 9,945 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Black Creek Investment Management Inc. | 7,951,626 | $318,224,000 | 10.49% |
| Healthcare Value Capital, LLC | 120,000 | $4,802,000 | 9.01% |
| KAHN BROTHERS GROUP INC | 1,605,014 | $64,232,661,000 | 8.03% |
| Eversept Partners, LP | 693,685 | $28,091,890 | 7.87% |
| EQUITY INVESTMENT CORP | 2,673,764 | $107,004,000 | 3.74% |
| Sio Capital Management, LLC | 379,500 | $15,188,000 | 3.66% |
| Martin Capital Partners, LLC | 115,448 | $4,620,000 | 3.27% |
| Circle Road Advisors LP | 53,028 | $2,122,000 | 3.10% |
| Keystone Financial Planning, Inc. | 156,968 | $6,282,000 | 3.07% |
| CAMG Solamere Management, LLC | 160,294 | $6,415,000 | 2.94% |